Con: β2-adrenergic agonists in ALI/ARDS - Not recommended or potentially harmful?

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 5, 2011, Pages 504-506

  Papazian, Laurent ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; SALBUTAMOL; SALMETEROL;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY PRESSURE; ALTITUDE; ANTIINFLAMMATORY ACTIVITY; ARTIFICIAL VENTILATION; CAPILLARY PERMEABILITY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG ARTERY PRESSURE; LUNG EDEMA; NONHUMAN; PRIORITY JOURNAL; SIDE EFFECT; TACHYCARDIA;

ACUTE LUNG INJURY; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ALBUTEROL; FEMALE; HUMANS; MALE;

EID: 80052455198     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201105-0852ED     Document Type: Editorial

References (15)

1. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163:1376-1383. (Pubitemid 32506602)
2. Bertorello AM, Ridge KM, Chibalin AV, Katz AI, Sznajder JI. Isoproterenol increases Na1-K1-ATPase activity by membrane insertion of alpha-subunits in lung alveolar cells. Am J Physiol 1999;276:L20-L27. (Pubitemid 29061660)
3. Mutlu GM, Koch WJ, Factor P. Alveolar epithelial beta 2-adrenergic receptors: their role in regulation of alveolar active sodium transport. Am J Respir Crit Care Med 2004;170:1270-1275. (Pubitemid 39657189)
4. Sartori C, Allemann Y, Duplain H, Lepori M, Egli M, Lipp E, Hutter D, Turini P, Hugli O, Cook S, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002;346:1631-1636. (Pubitemid 34755671)
5. Atabai K, Ware LB, Snider ME, Koch P, Daniel B, Nuckton TJ, Matthay MA. Aerosolized beta 2-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure. Intensive Care Med 2002;28:705-711. (Pubitemid 34639482)
6. Groshaus HE, Manocha S, Walley KR, Russell JA. Mechanisms of betareceptor stimulation-induced improvement of acute lung injury and pulmonary edema. Crit Care 2004;8:234-242. (Pubitemid 39144713)
7. Wright PE, Carmichael LC, Bernard GR. Effect of bronchodilators on lung mechanics in the acute respiratory distress syndrome (ARDS). Chest 1994;106:1517-1523. (Pubitemid 24346121)
8. Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006;173:281-287. (Pubitemid 43209082)
9. National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Randomized, placebo-controlled clinical trial of an aerosolized β2-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011;184:561-568.
10. Morgan EE, Hodnichak CM, Stader SM, Maender KC, Boja JW, Folkesson HG, Maron MB. Prolonged isoproterenol infusion impairs the ability of beta 2-agonists to increase alveolar liquid clearance. Am J Physiol Lung Cell Mol Physiol 2002;282:L666-L674.
11. Morgan EE, Stader SM, Hodnichak CM, Mavrich KE, Folkesson HG, Maron MB. Postreceptor defects in alveolar epithelial betaadrenergic signaling after prolonged isoproterenol infusion. Am J Physiol Lung Cell Mol Physiol 2003;285:L578-L583. (Pubitemid 37022858)
12. Braude S, Royston D. Infused salbutamol accentuates acid-induced lung injury in the rat. Clin Sci (Lond) 1986;71:205-209. (Pubitemid 16059801)
13. Peterson BT, Griffith DE, Connelly JC, Tate RW. Differential effects of salmeterol on lung endothelial and epithelial leakage in sheep. J Appl Physiol 1996;80:1666-1673. (Pubitemid 26143917)
14. Kuroki K, Takahashi HK, Iwagaki H, Murakami T, Kuinose M, Hamanaka S, Minami K, Nishibori M, Tanaka N, Tanemoto K. Beta 2-adrenergic receptor stimulation-induced immunosuppressive effects possibly through down-regulation of co-stimulatory molecules, ICAM-1, CD40 and CD14 on monocytes. J IntMed Res 2004;32:465-483. (Pubitemid 39255591)
15. Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011;6:147-163.